Gastric Neuroendocrine Tumors Drug Pipeline Analysis: Trend Analysis and Future Growth (2034)
Gastric neuroendocrine tumors (gNETs) are rare neoplasms originating from neuroendocrine cells in the stomach lining. They account for approximately 8% of all neuroendocrine tumors and affect about 4 in 100,000 individuals.
